Join the SmallCapReview mailing list.

LPCN Lipocine Inc.: A specialty pharmaceutical company developing innovative pharmaceutical products for use in men's and women's health using its proprietary drug delivery technologies. LPCN's clinical development pipeline includes three development programs.   More.
MYGN Myriad Genetics: A  personalized medicine company, that focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. MYGN has a collaboration with AstraZeneca for the development of an indication for BRACAnalysis CDx.    More.
AUPH Aurinia Pharmaceuticals: A late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted patient population suffering from serious disease states for which there is a high unmet medical need.  More. 
HISP Hispanica International: Is engaged in the distribution of proprietary, licensed and third party Hispanic and Ethnic food and beverages throughout the United States. The Company added over 1,400 retailers to now surpass 2,000 retail locations and will expand to over 5,000 retail locations. More.

Could This Small Cap Biotech Be The David To Mylan's Epipen Goliath?

3 Small Cap Stocks For the Long Term

These Small Cap Tech Stocks May Be Ready For A Breakout

Here's How Much A Bitcoin Is Actually Worth

How Shorting A Stock Works

Volume Leaders
52 Week Highs/Lows
Small-Cap Index
Check Futures Here
Level II Quotes
Stock Screener
Performance by Industry
After Hours Market
World Markets


Visit Our Resources Page

Past Articles Worth Reading











 Where Small Cap Stocks Thrive Since 1999                                           

4 Small Cap Semiconductor Stocks

Time To Look For Value In Small Cap Stocks... Small Cap Stocks should be next in line to participate more strongly, if not lead the next upbeat phase of the parade.

Hedge Funds Are In Love With Small Caps Again...

Lipocine (LPCN)


"Developing innovative pharmaceutical products for use in men's and women's health using its proprietary drug delivery technologies."

LPCN Investor Highlights

  • Product Development -  LPCN 1021 achieved primary endpoints confirming the efficacy of twice daily oral administration.
  • Innovation -  New Drug Application resubmission planned in the third quarter of 2017.
  • Progress: On April 24th Lipocine announced it had completed enrollment of the LPCN 1021 fixed dose trials.
  • Upcoming Milestones - Topline results from DV and DF studies for LPCN 1021 expected in June 2017.
  • Submission of LPCN 1107 Phase III protocol anticipated in 2Q:17.

To read more about LPCN Click Here.

Small Cap Of The Day...

Two Small Caps Buffet Would Buy...

7 Fast Growing Small Caps To Look At Now...

Making A Case For Small Cap Investing...

Small Caps Failing To Target Small Investors...

Last Time This Happened Small Caps Exploded Higher...

Top 10 Small Cap Dividend Stocks...

Playing The Spread...

Small Caps Now Hold The Key To This Market...

Small Cap IR By The Numbers... Average Small Cap IR budget: $224,000, with $78,000 spent on external services.

Dogs Of The Dow...  

10 Top S&P Small Cap 600 Dividend Dogs See 20% To 100% Net Gains...

Small Caps Post Biggest Gain In Three Months...

Small Cap Action Is Improving...

Myriad Genetics (MYGN)


"Myriad has the deepest diagnostic pipeline across the disease spectrum."

More on MYGN here...

Aurinia Pharmaceuticals (AUPH)



"Voclosporin has the potential to become a best in class medication and the first approved treatment for LN in the U.S. and Europe."

More on AUPH here...

Hispanica International (HISP)


"We Bring Latin America And The World To You."

More on HISP here...

Follow Us On


So Far, So Good For Small Cap Earnings

7 Tips For Investing In Small Cap Stocks

CANSLIM: A Proven Strategy For Chart Readers

Small Caps, Big Winners

Small Cap Investing Peter Lynch's Rules

15 Small Caps To Watch

How To Screen For Small Cap Stocks

Small Cap Rally Has A Long Way To Go

3 Small Caps That Could be Big Winners

Thinking Small - What To Look For In Small Cap Stocks

3 Small Cap Value Stocks

5 Small Caps Breaking Out To New Highs

Investing Or Betting

Timing The Market

The Foreign Exchange Market

2017 Review Of Small Cap Stocks

Dealing With Small Cap Volatility

Small-Cap Stocks -  The Quintessential Long Term Strategy


Messing Around With Small Caps In This Market Holding Pattern

Time To Build A Portfolio

From Buffet To Small Caps, How New Tax Plan Will Affect Wall Street

Going Social At Small Cap Stocks

How Mutual Funds Work

A Small Cap Pause That Refreshes

Why We Invest

Subscribers to our Free newsletter will receive stock reports and news alerts for small-cap stocks via email. You can sign-up here.

"A Primer In Small Cap Investing"® is a leading destination for small-cap picks and news. The Purpose of is to profile and bring awareness to companies with a market cap of less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap stocks to watch via various newswires. We will strive to bring you the undiscovered, the undervalued, and the oversold. does not give "buy" recommendations, price targets nor suggest entry and exit points.

"A Look at Small Cap Stocks that may no longer be Small Caps"




© 1999-2017 Any questions or comments regarding this site should be directed to